Clinical trial
Metabolomics of Neurocognitive Risk for Dementia in Diabetes
NCT03975309 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolomics of Neurocognitive Risk for Dementia in Diabetes
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 9, 2019
- Completion date
- May 23, 2023
- Enrollment
- 417 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes